Rekombinanter IL5 (Reslizumab Biosimilar) Antikörper (Biotin)
Kurzübersicht für Rekombinanter IL5 (Reslizumab Biosimilar) Antikörper (Biotin) (ABIN7829264)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Güteklasse
-
-
Verwendungszweck
- Biotinylated Anti-IL5(reslizumab biosimilar) mAb
-
Isotyp
- IgG4
-
-
-
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- IL5 (Reslizumab Biosimilar)
-
Andere Bezeichnung
- Reslizumab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
Synonyms Target:EDF,TRF,IL-5,Interleukin-5
Synonyms Antibody:CDP-835,CDP835,CDP 835,CEP-38072,CEP38072,CEP 38072,CINQAERO,CINQAIR,Cinquil,CTx-55700,CTx55700,Ctx 55700,DCP-835,DCP835,DCP 835,SCH 55700,SCH55600,SCH-55700,TRFK-5,TRFK 5,TRFK5 -
UniProt
- P05113
Target
-